4D PHARMA PLC's ticker is LBPSW and the CUSIP is 35085K117.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -92.0% | 55,653 | -11.7% | 0.00% | -100.0% |
| Q1 2022 | $25,000 | -99.0% | 63,026 | +75.8% | 0.00% | -98.5% |
| Q4 2021 | $2,600,000 | +4714.8% | 35,853 | -53.8% | 0.07% | +3200.0% |
| Q3 2021 | $54,000 | -38.6% | 77,566 | -13.5% | 0.00% | 0.0% |
| Q2 2021 | $88,000 | -35.3% | 89,649 | -28.3% | 0.00% | -60.0% |
| Q1 2021 | $136,000 | – | 125,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AQR Arbitrage LLC | 35,853 | $2,600,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,625 | $151,000 | 0.00% |
| Yakira Capital Management, Inc. | 47,326 | $25,000 | 0.00% |
| UBS Group AG | 1,320 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HRT FINANCIAL LP | 67,158 | $38,000 | 0.00% |